Retinoic acid regulates CD1d gene expression at the transcriptional level in human and rodent monocytic cells

Experimental Biology and Medicine

Volumn 232, Issue 4, 2007, Pages 488-494

  Chen, Qiuyan ^a   Ross, A Catharine ^a,b  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

galactosylceramide; Gene expression; Promoter; Retinoic acid response element

Indexed keywords

4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; ALPHA GALACTOSYLCERAMIDE; CD1D ANTIGEN; CYCLOHEXIMIDE; DACTINOMYCIN; RETINOIC ACID; RETINOIC ACID RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BIOLOGICAL ACTIVITY; CELL PROLIFERATION; CONTROLLED STUDY; DNA FLANKING REGION; DOSE RESPONSE; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; MONOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD1; ANTINEOPLASTIC AGENTS; BENZOATES; CELL PROLIFERATION; DACTINOMYCIN; GALACTOSYLCERAMIDES; GENE EXPRESSION REGULATION; GLYCOLIPIDS; HL-60 CELLS; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MACROPHAGES, PERITONEAL; MALE; MICE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, RETINOIC ACID; RESPONSE ELEMENTS; RNA, MESSENGER; SPLEEN; T-LYMPHOCYTES; TETRAHYDRONAPHTHALENES; TRANSCRIPTION, GENETIC; TRETINOIN; U937 CELLS;

RODENTIA;

EID: 34047149509     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Brigl M, Brenner MB. CD1: antigen presentation and T cell function. Annu Rev Immunol 22:817-890, 2004.
2. Skold M, Xiong X, Illarionov PA, Besra GS, Behar SM. Interplay of cytokines and microbial signals in regulation of CD1d expression and NKT cell activation. J Immunol 175:3584-3593, 2005.
3. Godfrey DI, Kronenberg M. Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest 114:1379-1388, 2004.
4. Skold M, Behar SM. Role of CD1d-restricted NKT cells in microbial immunity. Infect Immun 71:5447-5455, 2003.
5. Kinjo Y, Wu D, Kim G, Xing GW, Poles MA, Ho DD, Tsuji M, Kawahara K, Wong CH, Kronenberg M. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434:520-525, 2005.
6. Koch M, Stronge VS, Shepherd D, Gadola SD, Mathew B, Ritter G, Fersht AR, Besra GS, Schmidt RR, Jones EY, Cerundolo V. The crystal structure of human CD1d with and without alpha-galactosylceramide. Nat Immunol 6:819-826, 2005.
7. Zajonc DM, Cantu C 3rd, Mattner J, Zhou D, Savage PB, Bendelac A, Wilson IA, Teyton L. Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor. Nat Immunol 6:810-818, 2005.
8. Morita M, Motoki K, Akimoto K, Natori T, Sakai T, Sawa E, Yamaji K, Koezuka Y, Kobayashi E, Fukushima H. Structure-activity relationship of alpha-galactosylceramides against B16-bearing mice. J Med Chem 38:2176-2187, 1995.
9. Ross AC. Vitamin A, retinoids and immune responses. In: Livrea MA, Ed. Vitamin A and Retinoids: An update of biological aspects and clinical application. Basel, Switzerland: Birkauser Verlag, pp83-96, 2000.
10. Cui D, Moldoveanu Z, Stephensen CB. High-level dietary vitamin A enhances T-helper type 2 cytokine production and secretory immunoglobulin A response to influenza A virus infection in BALB/c mice. J Nutr 130:1132-1139, 2000.
11. DeCicco KL, Youngdahl JD, Ross AC. All-trans-retinoic acid and polyriboinosinic: polyribocytidylic acid in combination potentiate specific antibody production and cell-mediated immunity. Immunology 104:341-348, 2001.
12. Glasziou PP, Mackerras DE. Vitamin A supplementation in infectious diseases: a meta-analysis. BMJ 306:366-370, 1993.
13. Ma Y, Chen Q, Ross AC. Retinoic acid and polyriboinosinic: polyribocytidylic acid stimulate robust anti-tetanus antibody production while differentially regulating type 1/type 2 cytokines and lymphocyte populations. J Immunol 174:7961-7969, 2005.
14. Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song SY. Retinoic acid imprints gut-homing specificity on T cells. Immunity 21:527-538, 2004.
15. Seguin-Devaux C, Hanriot D, Dailloux M, Latger-Cannard V, Zannad F, Mertes PM, Longrois D, Devaux Y. Retinoic acid amplifies the host immune response to LPS through increased T lymphocytes number and LPS binding protein expression. Mol Cell Endocrinol 245:67-76, 2005.
16. Zhao Z, Ross AC. Retinoic acid repletion restores the number of leukocytes and their subsets and stimulates natural cytotoxicity in vitamin A-deficient rats. J Nutr 125:2064-2073, 1995.
17. Chen Q, Ross AC. Vitamin A and immune function: retinoic acid modulates population dynamics in antigen receptor and CD38-stimulated splenic B cells. Proc Natl Acad Sci U S A 102:14142-14149, 2005.
18. Estey EH, Giles FJ, Kantarjian H, O'Brien S, Cortes J, Freireich EJ, Lopez-Berestein G, Keating M. Molecular remissions induced by liposomal-encapsulated all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia. Blood 94:2230-2235, 1999.
19. Gaboli M, Gandini D, Delva L, Wang ZG, Pandolfi PP. Acute promyelocytic leukemia as a model for cross-talk between interferon and retinoic acid pathways: from molecular biology to clinical applications. Leuk Lymphoma 30:11-22, 1998.
20. Chen Q, Ross AC. Retinoic acid regulates cell cycle progression and cell differentiation in human monocytic THP-1 cells. Exp Cell Res 297:68-81, 2004.
21. Altucci L, Gronemeyer H. Retinoids and TRAIL: two cooperating actors to fight against cancer. Vitam Horm 67:319-345, 2004.
22. Mark M, Ghyselinck NB, Chambon P. Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. Annu Rev Pharmacol Toxicol 46:451-480, 2006.
23. Evans TR, Kaye SB. Retinoids: present role and future potential. Br J Cancer 80:1-8, 1999.
24. Nagy L, Thomazy VA, Heyman RA, Davies PJ. Retinoid-induced apoptosis in normal and neoplastic tissues. Cell Death Differ 5:11-19, 1998.
25. Chen Q, Ma Y, Ross AC. Opposing cytokine-specific effects of all trans-retinoic acid on the activation and expression of signal transducer and activator of transcription (STAT)-1 in THP-1 cells. Immunology 107:199-208, 2002.
26. James SY, Williams MA, Newland AC, Colston KW. Leukemia cell differentiation: cellular and molecular interactions of retinoids and vitamin D. Gen Pharmacol 32:143-154, 1999.
27. Pramanik R, Asplin JR, Lindeman C, Favus MJ, Bai S, Coe FL. Lipopolysaccharide negatively modulates vitamin D action by downregulating expression of vitamin D-induced VDR in human monocytic THP-1 cells. Cell Immunol 232:137-143, 2004.
28. Geng Y, Laslo P, Barton K, Wang CR. Transcriptional regulation of CD1D1 by Ets family transcription factors. J Immunol 175:1022-1029, 2005.
29. Chen QY, Jackson N. Human CD1D gene has TATA boxless dual promoters: an SP1-binding element determines the function of the proximal promoter. J Immunol 172:5512-5521, 2004.
30. Eckhoff C, Nau H. Identification and quantitation of all-trans- and 13-cis-retinoic acid and 13-cis-4-oxoretinoic acid in human plasma. J Lipid Res 31:1445-1454, 1990.
31. Forestier C, Park SH, Wei D, Benlagha K, Teyton L, Bendelac A. T cell development in mice expressing CD1d directed by a classical MHC class II promoter. J Immunol 171:4096-4104, 2003.
32. Xu H, Chun T, Colmone A, Nguyen H, Wang CR. Expression of CD1d under the control of a MHC class Ia promoter skews the development of NKT cells, but not CD8+ T cells. J Immunol 171:4105-4112, 2003.
33. Zimmer MI, Colmone A, Felio K, Xu H, Ma A, Wang CR. A cell-type specific CD1d expression program modulates invariant NKT cell development and function. J Immunol 176:1421-1430, 2006.
34. Szatmari I, Pap A, Ruhl R, Ma JX, Illarionov PA, Besra GS, Rajnavolgyi E, Dezso B, Nagy L. PPAR-gamma controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells. J Exp Med 203:2351-2362, 2006.
35. Iwata M, Eshima Y, Kagechika H. Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors. Int Immunol 15:1017-1025, 2003.